Document is current
Any future updates will be listed below
-
Authors
Sieberts, Solveig K. https://orcid.org/0000-0003-1033-0954
Schaff, Jennifer
Duda, Marlena
Pataki, Bálint Ármin
Sun, Ming
Snyder, Phil https://orcid.org/0000-0002-6967-2185
Daneault, Jean-Francois
Parisi, Federico
Costante, Gianluca
Rubin, Udi
Banda, Peter
Chae, Yooree
Chaibub Neto, Elias
Dorsey, E. Ray
Aydın, Zafer
Chen, Aipeng
Elo, Laura L. https://orcid.org/0000-0001-5648-4532
Espino, Carlos
Glaab, Enrico https://orcid.org/0000-0003-3977-7469
Goan, Ethan
Golabchi, Fatemeh Noushin
Görmez, Yasin
Jaakkola, Maria K.
Jonnagaddala, Jitendra https://orcid.org/0000-0002-9912-2344
Klén, Riku
Li, Dongmei
McDaniel, Christian
Perrin, Dimitri https://orcid.org/0000-0002-4007-5256
Perumal, Thanneer M.
Rad, Nastaran Mohammadian
Rainaldi, Erin https://orcid.org/0000-0003-1082-7055
Sapienza, Stefano
Schwab, Patrick
Shokhirev, Nikolai
Venäläinen, Mikko S. https://orcid.org/0000-0003-1777-4259
Vergara-Diaz, Gloria
Zhang, Yuqian https://orcid.org/0000-0002-7538-872X
,
Abrami, Avner
Adhikary, Aditya
Agurto, Carla
Bhalla, Sherry
Bilgin, Halil
Caggiano, Vittorio
Cheng, Jun
Deng, Eden
Gan, Qiwei
Girsa, Rajan
Han, Zhi
Heisig, Stephen
Huang, Kun
Jahandideh, Samad
Kopp, Wolfgang
Kurz, Christoph F.
Lichtner, Gregor
Norel, Raquel
Raghava, G. P. S.
Sethi, Tavpritesh
Shawen, Nicholas
Tripathi, Vaibhav
Tsai, Matthew
Wang, Tongxin
Wu, Yi
Zhang, Jie
Zhang, Xinyu
Wang, Yuanjia
Guan, Yuanfang https://orcid.org/0000-0001-8275-2852
Brunner, Daniela
Bonato, Paolo https://orcid.org/0000-0002-1818-1714
Mangravite, Lara M. https://orcid.org/0000-0001-7841-3612
Omberg, Larsson https://orcid.org/0000-0002-4719-9120
- License Information
-
More Information
Article History
Received: 16 April 2020
Accepted: 8 February 2021
First Online: 19 March 2021
Competing interests
: J.F.D. holds equity shares of Medapplets. E.R.D. has received honoraria for speaking at American Academy of Neurology courses, American Neurological Association, and University of Michigan; received compensation for consulting services from 23andMe, Abbott, Abbvie, American Well, Biogen, Clintrex, DeciBio, Denali Therapeutics, GlaxoSmithKline, Grand Rounds, Karger, Lundbeck, MC10, MedAvante, Medical-legal services, Mednick Associates, National Institute of Neurological Disorders and Stroke, Olson Research Group, Optio, Origent Data Sciences, Inc., Prilenia, Putnam Associates, Roche, Sanofi, Shire, Sunovion Pharma, Teva, UCB and Voyager Therapeutics; research support from Abbvie, Acadia Pharmaceuticals, AMC Health, Biosensics, Burroughs Wellcome Fund, Davis Phinney Foundation, Duke University, Food and Drug Administration, GlaxoSmithKline, Greater Rochester Health Foundation, Huntington Study Group, Michael J. Fox Foundation, National Institutes of Health/National Institute of Neurological Disorders and Stroke, National Science Foundation, Nuredis Pharmaceuticals, Patient-Centered Outcomes Research Institute, Pfizer, Prana Biotechnology, Raptor Pharmaceuticals, Roche, Safra Foundation, Teva Pharmaceuticals, University of California Irvine; editorial services for Karger Publications; and ownership interests with Blackfynn (data integration company) and Grand Rounds (second opinion service). F.N.G. is currently a full time employee of Draeger Medical Systems. E.R. is an employee of Verily Life Sciences, receiving salary and equity compensation. Y.G. receives research funding from Merck KGaA, Ryss Tech and Amazon, receives personal payment from Genentech, Inc, Eli Lilly and Company, F. Hoffmann-La Roche AG, serves as chief scientist and holds equity shares at Ann Arbor Algorithms Inc. D.B. was salaried President of Early Signal Foundation at the time of this work, and is currently salaried Executive Director of Digital Health for Cohen Veterans Bioscience. P. Bonato has received grant support from the American Heart Association, the Department of Defense, the Michael J Fox Foundation, the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Peabody Foundation including sub-awards on NIH and NSF SBIR grants from Barrett Technology (Newton MA), BioSensics (Watertown MA) and Veristride (Salt Lake City UT). He has also received grant support from Emerge Diagnostics (Carlsbad CA), MC10 (Lexington MA), Mitsui Chemicals (Tokyo Japan), Pfizer (New York City NY), Shimmer Research (Dublin Ireland), and SynPhNe (Singapore). He serves in an advisory role the Michael J Fox Foundation, the NIH-funded Center for Translation of Rehabilitation Engineering Advances and Technology, and the NIH-funded New England Pediatric Device Consortium. He also serves on the Scientific Advisory Boards of Hocoma AG (Zurich Switzerland), Trexo (Toronto Canada), and ABLE Human Motion (Barcelona, Spain) in an uncompensated role. Consortium authors A.A., C.A., V.C., S.H., and R.N. report that their employer, IBM Research, is the research branch of IBM Corporation, and V.C., S.H., and R.N. report that they own stock in IBM Corporation. All other authors report no competing interests.
